Description
Multiple cross-site scripting (XSS) vulnerabilities in the Web Console in the Application Server in Red Hat JBoss Enterprise Application Platform (aka JBoss EAP or JBEAP) 4.2.0 before 4.2.0.CP08, 4.2.2GA, 4.3 before 4.3.0.CP07, and 5.1.0GA allow remote attackers to inject arbitrary web script or HTML via the (1) monitorName, (2) objectName, (3) attribute, or (4) period parameter to createSnapshot.jsp, or the (5) monitorName, (6) objectName, (7) attribute, (8) threshold, (9) period, or (10) enabled parameter to createThresholdMonitor.jsp. NOTE: some of these details are obtained from third party information.
Published: 2009-12-15
Score: 4.3 Medium
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

No analysis available yet.

Remediation

No remediation available yet.

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2009-2401 Multiple cross-site scripting (XSS) vulnerabilities in the Web Console in the Application Server in Red Hat JBoss Enterprise Application Platform (aka JBoss EAP or JBEAP) 4.2.0 before 4.2.0.CP08, 4.2.2GA, 4.3 before 4.3.0.CP07, and 5.1.0GA allow remote attackers to inject arbitrary web script or HTML via the (1) monitorName, (2) objectName, (3) attribute, or (4) period parameter to createSnapshot.jsp, or the (5) monitorName, (6) objectName, (7) attribute, (8) threshold, (9) period, or (10) enabled parameter to createThresholdMonitor.jsp. NOTE: some of these details are obtained from third party information.
History

No history.

Subscriptions

Redhat Jboss Enterprise Application Platform
cve-icon MITRE

Status: PUBLISHED

Assigner: redhat

Published:

Updated: 2024-08-07T05:52:15.197Z

Reserved: 2009-07-09T00:00:00.000Z

Link: CVE-2009-2405

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Deferred

Published: 2009-12-15T18:30:00.407

Modified: 2025-04-09T00:30:58.490

Link: CVE-2009-2405

cve-icon Redhat

Severity : Moderate

Publid Date: 2009-07-22T00:00:00Z

Links: CVE-2009-2405 - Bugzilla

cve-icon OpenCVE Enrichment

No data.

Weaknesses